RankAlpha logo
Back to Rankings

ACRV

Acrivon TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The bull case is that ACR-368's serous endometrial cancer signal holds up in the H2 2026 simultaneous interim analysis and that ACR-2316 continues to show differentiated activity outside typical WEE1-sensitive settings, allowing the market to revalue the platform from a deeply discounted base [#SEC-8K-2026-05-13].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
ACR-2316 remains early-stage, so promising tolerability and activity commentary may not translate into broader efficacy or durable expansion-phase data.
Momentum
88
Value
58
Sentiment
28
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.30 · Bull $2.40 · Bear $0.80
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-11 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $11.50
Why
Momentum88 · Δ7d -
Value58 · Δ7d -0.4
Sentiment28 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
88
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
39% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.0
Sentiment
28
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 87.8 / Value 58.3 / Sentiment 27.7

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$74.9M
Beta
-
Shares Out
42.8M
P/E (TTM) · Derived
-0.9
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.02
Rev YoY
-
EPS YoY
-4.2%
Gross Margin
-
Op Margin
-
Net Debt
-$115.87M
Current Ratio
8.98
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology